References
- McTavish, D., Campoli-Richards, D., Sorkin, E.M., 1993, Carvedilol: a review of its pharmacological and pharmacokinetic properties, and therapeutic efficacy, Drugs 45, 232-258.
- Dunn, C.J., Lea, A.P., Wagstaff, A.J., 1997, Carvedilol: a reappraisal of its pharmacological properties and therapeutical use in cardiovascular disorders, Drugs, 54, 161-185. https://doi.org/10.2165/00003495-199754010-00015
- Robert, R., Ruffolo, R.R., Boyle, D.A., Brooks, D.P., Feuerstein, G.Z., Venuti, R.P., Lukas M.A., Paste, G., 1992, Carvedilol: a novel cardiovascular drug with multiple actions, Cardiovasc Drug Rev, 10(2), 127-157. https://doi.org/10.1111/j.1527-3466.1992.tb00242.x
- Tanwar, Y.S., Chauhan C.S., Sharma, A., 2007, Development and evaluation of carvedilol transdermal patches, Acta Pharm, 57, 151-159. https://doi.org/10.2478/v10007-007-0012-x
- Mcphillips, J.J., Schwerner, G.T., Scott, D.I., Zinny, M., Patterson, K., 1988, Effects of carvedilol on blood pressure in patients with mild to moderate hypertension, Drugs, 36, 82-91. https://doi.org/10.2165/00003495-198800366-00015
- Kim, S.M., Shin, S.B., Kim, J.H., Kown, I.H., Kim, Y.H., Lee, S.N., Cho H.Y., Lee, Y.B., 2008, Bioequivalence of Cadilan tablet 12.5 mg to Dilatrend tablet 12.5 mg (Carvedilol 12.5 mg), J Kor Pharm Sci, 38(6), 413-419. https://doi.org/10.4333/KPS.2008.38.6.413
- Loftsson, T., Vogensen, S.B., Desbos, C., Jansook, P., 2008, Carvedilol: solubilization and cyclodextrin complexation: a technical note, AAPS Pharm Sci Tech, 9, 425-430. https://doi.org/10.1208/s12249-008-9055-7
- Neugebauer, G., Akpan, W., Mollendorff, E.V., Neuber P., Reiff, K., 1987, Pharmacokinetics and disposition of carvedilol in human, J Cardiovas Pharmacol, 10, 85-88.
- Mura, P., Cirri M., Faucci, M.T., 2002, Investigation of the effects of grinding and co-grinding on physicochemical properties of glisentide, J Pharm Biomed Anal, 30, 227-237. https://doi.org/10.1016/S0731-7085(02)00252-2
-
Kubo H., Mizobe, M., 1997, Improvement of dissolution rate and oral bioavailability of a sparingly water-soluble drug, (
${\pm}$ )-5- [[2-(2-naphthalenylmethyl)-5-benzoxazolyl]-methyl]-2,4-thiazolidinedione, in co-ground mixture with D-mannitol, Biol Pharm Bull, 20, 460-463. https://doi.org/10.1248/bpb.20.460 - Kawashima, Y., Saito M., Takenaka, H., 1975, Improvement of solubility and dissolution rate of poorly water-soluble salicylic acid by a spray-drying technique, J Pharm Pharmacol, 27, 1-5. https://doi.org/10.1111/j.2042-7158.1975.tb09369.x
- Sekiguchi, K., Obi, N., 1961, Studies on the absorption of a eutectic mixture. I. A comparison of the behavior of a eutectic mixture of sulfathiazole and that of ordinary sulfatiazole in man, Chem Pharm Bull, 9, 193-198.
- Leuner, C., Dressman, J., 2000, Improving drug solubility for oral delivery using solid dispersions, Eur J Pharm Biopharm, 50, 47-60. https://doi.org/10.1016/S0939-6411(00)00076-X
- Chiou, W.L., Riegelman, S., 1971, Pharmaceutical applications of solid dispersion systems, J Pharm Sci, 60, 1281-1302. https://doi.org/10.1002/jps.2600600902
- Hirasawa, N., Ishise, S., Miyata, H., Danjo, K., 2003, Physicochemical characterization and drug release studies of nilvadipine solid dispersions using a water-insoluble polymer as a carrier, Drug Dev Ind Pharm, 29, 339-344. https://doi.org/10.1081/DDC-120018207
- Jeong, J.K., Khang, G., Rhee, J.M., Shin, H.C., Lee, H.B., 2000. Effect of molecular weight and mixture ratio of PVP on improving the bioavailability of ipriflavone, J Korean Pharm. Sci. 30(4), 235-239.
- Jeong, J.K., Kim, J.H., Khang, G., Rhee, J.M., Lee, H.B., 2002. The preparation and characterization of solid dispersion of ipriflavone with PVP, J Korean Pharm Sci. 32(3), 173-179. https://doi.org/10.4333/KPS.2002.32.3.173
- Shah, U., Augsburger, L., 2001, Evaluation of the functional equivalence of crospovidone NF from different sources, Pharm Dev Technol, 6, 39-51. https://doi.org/10.1081/PDT-100000012
- Srinarong, P., Faber, J.H., Visser, M.R., Hinrichs, W.L.J., Frijlinl, H.W., 2009, Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants, Eur J Pharm BioPharm, 73(1), 154-161. https://doi.org/10.1016/j.ejpb.2009.05.006
- Doherty, C., York, P., 1989, Microenvironmental pH control of drug dissolution, Int J Pharm, 50, 223-232. https://doi.org/10.1016/0378-5173(89)90126-9
- Siepe, S., Lueckel, B., Kramer, A., Ries, A., Gurny, R., 2006, Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH, Int J Pharm, 316, 14-20 https://doi.org/10.1016/j.ijpharm.2006.02.021
- Thao, T.D., Phuong, H.L., Choi, H.G., Han, H.K., Lee, B.J., 2010, The role of acidifier in solid dispersion and physical mixtures, Int J Pharm, 384, 60-66. https://doi.org/10.1016/j.ijpharm.2009.09.039
- Cui, Y., Kim, S.S., Park, E.S., Chi, S.C., 2002, Formation of sustained- release matrix tablets of nipedifine, J Kor Pharm Sci, 32(2), 95-101.
- Virtanen, S., Salokangsa, H., Yliruusi, J., 2008, The effect of mixing time of the magnesium stearate on crushing strengths of tablets, Eur J Pharm Sci, 34S, S25-S29.
- Guchardi, R., Frei, M., John, E., Kaerger J.S., 2008, Influence of fine lactose and magnesium stearate on low dose dry power inhaler formations, Int J Pharm, 348, 10-17. https://doi.org/10.1016/j.ijpharm.2007.06.041
- Mehrotra, A., Llusa, M., Faqih, A., Levin, M., Muzzio, F.J., 2007, Influence of shear intensity and total shear on properties of blends and tablets of lactose and cellulose lubricated with magnesium stearate, Int J Pharm, 336, 284-291. https://doi.org/10.1016/j.ijpharm.2006.12.013
- Oh, M.J., Shim, J.B., Lee, E.Y., Yoo, H., Cho, W.H., Lim, D.K., Lee, D., Khang, G., 2011, Molecular effect of PVP on the release property of carvedilol solid dispersion, J Pharma Investi, 41(3), 179-184. https://doi.org/10.4333/KPS.2011.41.3.179